|
| 1 |
Immune Checkpoint Inhibitors and Endocrine Disorders: A Position Statement from the Korean Endocrine Society
Hyemi Kwon, Eun Roh, Chang Ho Ahn, Hee Kyung Kim, Cheol Ryong Ku, Kyong Yeun Jung, Ju Hee Lee, Eun Heui Kim, Sunghwan Suh, Sangmo Hong, Jeonghoon Ha, Jun Sung Moon, Jin Hwa Kim, Mi-kyung Kim
Endocrinol Metab.2022;37(6):839-850. Published online 2022 December 26
DOI: http://dx.doi.org/10.3803/EnM.2022.1627
|
|
| 2 |
Comprehensive Molecular Characterization of Soft Tissue Sarcoma for Prediction of Pazopanib-Based Treatment Response
Jung Yong Hong, Hee Jin Cho, Kum-Hee Yun, Young Han Lee, Seung Hyun Kim, Wooyeol Baek, Sang Kyum Kim, Yurimi Lee, Yoon-La Choi, Minsuk Kwon, Hyo Song Kim, Jeeyun Lee
Cancer Res Treat.2023;55(2):671-683. Published online 2022 September 27
DOI: http://dx.doi.org/10.4143/crt.2022.251
|
|
| 3 |
Characteristics and usefulness of transabdominal ultrasonography in immune-mediated colitis
Kensuke Sakurai, Takehiko Katsurada, Mutsumi Nishida, Satomi Omotehara, Shinya Fukushima, Shinsuke Otagiri, Kazunori Nagashima, Reizo Onishi, Ryo Takagi, Yoshito Komatsu, Naoya Sakamoto
Intest Res.2023;21(1):126-136. Published online 2022 July 22
DOI: http://dx.doi.org/10.5217/ir.2021.00166
|
|
| 4 |
Diffuse large B-cell lymphoma (DLBCL) is infiltrated with activated CD8+ T-cells despite immune checkpoint signaling
Adam M. Greenbaum, Jonathan R. Fromm, Ajay K. Gopal, A. McGarry Houghton
Blood Res.2022;57(2):117-128. Published online 2022 June 30
DOI: http://dx.doi.org/10.5045/br.2022.2021145
|
|
| 5 |
Immune checkpoint inhibitors for solid organ transplant recipients: clinical updates
Shun Kawashima, Kole Joachim, Maen Abdelrahim, Ala Abudayyeh, Kenar D. Jhaveri, Naoka Murakami
|
|
| 6 |
Molecular and Immune Profiling of Syngeneic Mouse Models Predict Response to Immune Checkpoint Inhibitors in Gastric Cancer
Dagyeong Lee, Junyong Choi, Hye Jeong Oh, In-Hye Ham, Sung Hak Lee, Sachiyo Nomura, Sang-Uk Han, Hoon Hur
|
|
| 7 |
Lumbosacral polyradiculoneuropathy associated with combination therapy of nivolumab and ipilimumab
Eun Bin Cho, Seung Joo Kim, Tae-Won Yang, Seunguk Jung, Heejeong Jeong, Ki-Jong Park
|
|
| 8 |
Concurrent transarterial radioembolization and combination atezolizumab/bevacizumab treatment of infiltrative hepatocellular carcinoma with portal vein tumor thrombosis: a case report
Min Kyung Park, Su Jong Yu
|
|
| 9 |
Human Leukocyte Antigens and Biomarkers in Type 1 Diabetes Mellitus Induced by Immune-Checkpoint Inhibitors
Hidefumi Inaba, Yosuke Kaido, Saya Ito, Tomonao Hirobata, Gen Inoue, Takakazu Sugita, Yuki Yamamoto, Masatoshi Jinnin, Hiroaki Kimura, Tomoko Kobayashi, Shintaro Iwama, Hiroshi Arima, Takaaki Matsuoka
Endocrinol Metab.2022;37(1):84-95. Published online 2022 February 28
DOI: http://dx.doi.org/10.3803/EnM.2021.1282
|
|
| 10 |
Current Immunotherapeutic Approaches for Malignant Gliomas
Myung-Hoon Han, Choong Hyun Kim
|
|
| 11 |
Histopathologic and Molecular Biomarkers of PD-1/PD-L1 Inhibitor Treatment Response among Patients with Microsatellite Instability–High Colon Cancer
Jaewon Hyung, Eun Jeong Cho, Jihun Kim, Jwa Hoon Kim, Jeong Eun Kim, Yong Sang Hong, Tae Won Kim, Chang Ohk Sung, Sun Young Kim
Cancer Res Treat.2022;54(4):1175-1190. Published online 2022 January 12
DOI: http://dx.doi.org/10.4143/crt.2021.1133
|
|
| 12 |
Prognostic impact of serum soluble PD-1 and ADV score for living donor liver transplantation in patients with previously untreated hepatocellular carcinoma
Shin Hwang, Kyung Jin Lee, Deok-Bog Moon, Gi-Won Song, Dong-Hwan Jung, Yun Kyu Kim, Hunji Yang, Da Eun An, Sion Lee, Sung-Gyu Lee
|
|
| 13 |
Frequency of Mismatch Repair Deficiency/High Microsatellite Instability and Its Role as a Predictive Biomarker of Response to Immune Checkpoint Inhibitors in Gynecologic Cancers
Joseph J. Noh, Min Kyu Kim, Min Chul Choi, Jeong-Won Lee, Hyun Park, Sang Geun Jung, Won Duk Joo, Seung Hun Song, Chan Lee
Cancer Res Treat.2022;54(4):1200-1208. Published online 2021 December 13
DOI: http://dx.doi.org/10.4143/crt.2021.828
|
|
| 14 |
Clinical Efficacy of Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer Patients with Liver Metastases: A Network Meta-Analysis of Nine Randomized Controlled Trials
Qing Yin, Longguo Dai, Ruizhu Sun, Ping Ke, Liya Liu, Bo Jiang
Cancer Res Treat.2022;54(3):803-816. Published online 2021 October 25
DOI: http://dx.doi.org/10.4143/crt.2021.764
|
|
| 15 |
Infiltrative hepatocellular carcinoma with multiple lung metastasis completely cured using nivolumab: a case report
Ji Eun Han, Hyo Jung Cho, Soon Sun Kim, Jae Youn Cheong
J Liver Cancer.2021;21(2):169-176. Published online 2021 September 30
DOI: http://dx.doi.org/10.17998/jlc.2021.08.26
|
|
| 16 |
Systemic therapy for advanced hepatocellular carcinoma: consideration for selecting second-line treatment
Bo Hyun Kim, Joong-Won Park
J Liver Cancer.2021;21(2):124-138. Published online 2021 September 30
DOI: http://dx.doi.org/10.17998/jlc.2021.09.23
|
|
| 17 |
Advances in immune checkpoint inhibitors for hepatocellular carcinoma
Ji Won Han, Su-Hyung Park
J Liver Cancer.2021;21(2):139-145. Published online 2021 September 30
DOI: http://dx.doi.org/10.17998/jlc.2021.09.24
|
|
| 18 |
Histone Deacetylase as a Valuable Predictive Biomarker and Therapeutic Target in Immunotherapy for Non–Small Cell Lung Cancer
Hyun-Seock Shin, Juwhan Choi, Jinhwan Lee, Sung Yong Lee
Cancer Res Treat.2022;54(2):458-468. Published online 2021 September 10
DOI: http://dx.doi.org/10.4143/crt.2021.425
|
|
| 19 |
Engineering a High-Affinity PD-1 Peptide for Optimized Immune Cell–Mediated Tumor Therapy
Yilei Chen, Hongxing Huang, Yin Liu, Zhanghao Wang, Lili Wang, Quanxiao Wang, Yan Zhang, Hua Wang
Cancer Res Treat.2022;54(2):362-374. Published online 2021 August 3
DOI: http://dx.doi.org/10.4143/crt.2021.424
|
|
| 20 |
Comparison of the Predictive Power of a Combination versus Individual Biomarker Testing in Non–Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
Hyojin Kim, Hyun Jung Kwon, Eun Sun Kim, Soohyeon Kwon, Kyoung Jin Suh, Se Hyun Kim, Yu Jung Kim, Jong Seok Lee, Jin-Haeng Chung
|
|
